FIELD: medicine, pharmaceutical technology, pharmacy.
SUBSTANCE: invention relates to granulated composition containing 11-[4-[2-(2-hydroxyethyl)ethyl]-1-piperazinyl]dibenzo[b,f][1,4]thiazepine (quetiapine) or its pharmaceutically acceptable salt, preferably quetiapine fumarate, as an active substance and a water-soluble binding agent. Invention relates to a method for preparing this composition and to a method for treatment of patients with nervous system diseases such as psychotic states including schizophrenia. Invention alleviates dosing of drugs by patients in required dose and solves problem concerning maintenance of regimen and schedule of treatment.
EFFECT: improved and valuable properties of composition.
16 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PERORAL PREPARATION AND METHOD OF ITS PRODUCTION | 2005 |
|
RU2376013C2 |
| PHARMACEUTICAL COMPOSITION, METHOD FOR ITS OBTAINING, METHOD FOR TREATING PSYCHOTIC STATES AND HYPERACTIVITY | 1997 |
|
RU2201754C2 |
| METHOD FOR PREPARING QUETIAPINE AND INTERMEDIATE COMPOUNDS | 2001 |
|
RU2258067C2 |
| TABLET QUETIAPINE WITH PROLONGED RELEASE AND SYNTHESIS METHOD THEREOF | 2015 |
|
RU2588840C1 |
| CRYSTALLINE DERIVATIVE OF DIBENZOTHIAZEPINE, METHOD FOR PREPARING AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1998 |
|
RU2224754C2 |
| SYSTEMS OF MEDICATION DELIVERY, INCLUDING SOLID SOLUTIONS OF WEAK-BASE MEDICATIONS | 2007 |
|
RU2434630C2 |
| SYSTEMS OF DELIVERING MEDICAL SUBSTANCES, INCLUDING WEAKLY BASIC MEDICINAL SUBSTANCES AND ORGANIC ACIDS | 2009 |
|
RU2504362C2 |
| SOLID MOLECULAR DISPERSION | 2012 |
|
RU2600816C2 |
| SYSTEMS OF MEDICATION DELIVERY, CONTAINING WEAK-BASE MEDICATIONS AND ORGANIC ACIDS | 2007 |
|
RU2428176C2 |
| CONJUGATES AND SMALL MOLECULES, INTERACTING WITH CD16a RECEPTOR | 2013 |
|
RU2519546C1 |
